Hosted by Biogen, the Colloquium brings together leading investigators and physicians with patients, partners and supporters to discuss progress in addressing nano-rare illnessesn-Lorem has ...
The "Positive Persuading and Influencing Skills for Pharma Professionals (Nov 10th - Nov 13th, 2025)" training has been added to ResearchAndMarkets.com's offering.This workshop will help you to build ...
Neuraptive Therapeutics, Inc., a biotechnology company focused on developing novel therapies to improve outcomes in ...
Germany is the first European country to launch the product, with further rollouts across Europe to followThe next-generation ...
Key CMC achievements advance EB-003 on the path to first-in-human trialsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric ...
Global pharma and academia have launched a consortium to develop OpenFold3, an open-source AI model for drug discovery that ...
Peer-recognized immigration leader to drive scale, transformation, and differentiation in client service deliveryNEW YORK--(BUSINESS WIRE)--Vialto Partners, a global leader in workforce mobility, tax, ...
A new study has revealed how NHS waiting lists are pushing patients into risky choices - with some delaying or even avoiding ...
Oticara, an emerging pharmaceutical company advancing physician-delivered treatments for chronic rhinosinusitis (CRS), today ...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it has begun opening ...
Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screeningWALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today ...
Redditch Medical, the UK company specialising in cleanroom contamination control solutions, has been acquired by German ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback